Skip to main content

CARACTERIZACION DE NUEVOS MARCADORES CELULARES Y ESTUDIO DE ANTICUERPOS GLICOSILADOS EN EL MANEJO DE LA TUBERCULOSIS

PI18/00411

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2018
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (CIBER)
Execution centre HOSPITAL GERMANS TRIAS I PUJOL

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Study of CD27 and CCR4 markers on specific CD4+ T-cells as immune tools for active and latent tuberculosis management

  • Latorre, Irene|||0000-0001-8159-2455
  • Fernández Sanmartin, Marco Antonio
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Vila, Sergi
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Centeno, Carmen
  • Ruiz Manzano, Juan|||0000-0001-7213-7346
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Molina-Pinargote, Israel|||0000-0002-9160-0284
  • González, Yoel-Domingo|||0000-0002-5991-8938
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Luque-Chacón, Lydia
  • Sabriá, Josefina
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Domínguez, José|||0000-0001-7888-0309
The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4+ T-cells producing IFN-γ+ with a low expression of CD27 have been described as an active TB marker. In addition, there are unknown homing receptors related to TB, such as CCR4, which might be useful for understanding TB pathogenesis. The aim of our study is focused on the assessment of several T-cell subsets to understand immune-mechanisms in TB. This phenotypic immune characterization is based on the study of the specific immune responses of T-cells expressing CD27 and/or CCR4 homing markers. Subjects enrolled in the study were: (i) 22 adult patients with active TB, and (ii) 26 individuals with latent TB infection (LTBI). Blood samples were drawn from each patient. The expression of CD27 and/or CCR4 markers were analyzed within CD4+ T-cells producing: (i) IFN-γ+, (ii) TNF-α+, (iii) TNF-α+IFN-γ+, and (iv) IFN-γ+ and/or TNF-α+. The percentage of CD27. within all CD4+ T-cell populations analyzed was significantly higher on active TB compared to LTBI after PPD or ESAT-6/CFP-10 stimulation. As previously reported, a ratio based on the CD27 median fluorescence intensity (MFI) was also explored (MFI of CD27 in CD4+ T-cells over MFI of CD27 in IFN-γ+CD4+ T-cells), being significantly increased during disease (p < 0.0001 after PPD or ESAT-6/CFP-10 stimulation). This ratio was also assessed on the other CD4+ T-cells functional profiles after specific stimulation, being significantly associated with active TB. Highest diagnostic accuracies for active TB (AUC ≥ 0.91) were achieved for: (i) CD27 within IFN-γ+TNF-α+CD4+ T-cells in response to ESAT-6/CFP-10, (ii) CD27 and CCR4 markers together within IFN-γ+CD4+ T-cells in response to PPD, and (iii) CD27 MFI ratio performed on IFN-γ+TNF-α+CD4+ T-cells after ESAT-6/CFP-10 stimulation. The lowest diagnostic accuracy was observed when CCR4 marker was evaluated alone (AUC ≤ 0.77). CD27 and CCR4 expression detection could serve as a good method for immunodiagnosis. Moreover, the immunological characterization of markers/subset populations could be a promising tool for understanding the biological basis of the disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cell-Mediated Immune Responses to in vivo -Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups

  • Coppola, Mariateresa
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • van Meijgaarden, Krista E.
  • Latorre, Irene|||0000-0001-8159-2455
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • García-García, Esther
  • Franken, Kees L. M. C.
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Sabriá, Josefina
  • Sánchez Montalvá, Adrián|||0000-0002-2194-5447
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Geluk, Annemieke
  • Domínguez, José|||0000-0001-7888-0309
  • Ottenhoff, Tom H. M.
A quarter of the global human population is estimated to be latently infected by Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). TB remains the global leading cause of death by a single pathogen and ranks among the top-10 causes of overall global mortality. Current immunodiagnostic tests cannot discriminate between latent, active and past TB, nor predict progression of latent infection to active disease. The only registered TB vaccine, Bacillus Calmette-Guérin (BCG), does not adequately prevent pulmonary TB in adolescents and adults, thus permitting continued TB-transmission. Several Mtb proteins, mostly discovered through IFN-γ centered approaches, have been proposed as targets for new TB-diagnostic tests or -vaccines. Recently, however, we identified novel Mtb antigens capable of eliciting multiple cytokines, including antigens that did not induce IFN-γ but several other cytokines. These antigens had been selected based on high Mtb gene-expression in the lung in vivo, and have been termed in vivo expressed (IVE-TB) antigens. Here, we extend and validate our previous findings in an independent Southern European cohort, consisting of adults and adolescents with either LTBI or TB. Our results confirm that responses to IVE-TB antigens, and also DosR-regulon and Rpf stage-specific Mtb antigens are marked by multiple cytokines, including strong responses, such as for TNF-α, in the absence of detectable IFN-γ production. Except for TNF-α, the magnitude of those responses were significantly higher in LTBI subjects. Additional unbiased analyses of high dimensional flow-cytometry data revealed that TNF-α+ cells responding to Mtb antigens comprised 17 highly heterogeneous cell types. Among these 17 TNF-α+ cells clusters identified, those with CD8+TEMRA or CD8+CD4+ phenotypes, defined by the expression of multiple intracellular markers, were the most prominent in adult LTBI, while CD14+ TNF-α+ myeloid-like clusters were mostly abundant in adolescent LTBI. Our findings, although limited to a small cohort, stress the importance of assessing broader immune responses than IFN-γ alone in Mtb antigen discovery as well as the importance of screening individuals of different age groups. In addition, our results provide proof of concept showing how unbiased multidimensional multiparametric cell subset analysis can identify unanticipated blood cell subsets that could play a role in the immune response against Mtb.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination

  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Blauenfeldt, Thomas
  • García-García, Esther
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Sabriá, Fina
  • Sánchez Montalvá, Adrián|||0000-0002-2194-5447
  • Ruiz Manzano, Juan|||0000-0001-7213-7346
  • Pilarte, Jose
  • Jiménez, M. A.
  • Centeno, Carmen
  • Martos, Carmen
  • Molina-Pinargote, Israel|||0000-0002-9160-0284
  • González, Yoel-Domingo|||0000-0002-5991-8938
  • Santiago, Javier
  • Cantos, Adela
  • Casas, Irma|||0000-0002-5902-5777
  • Guerola, Rosa
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Andersen, Peter Lawætz
  • Latorre, Irene|||0000-0001-8159-2455
  • Ruhwald, Morten|||0000-0002-1597-441X
  • Domínguez, José|||0000-0001-7888-0309
Interferon (IFN)-γ release assays (IGRAs) are used to diagnose latent tuberculosis (TB) infection (LTBI). To improve the accuracy of these tests, different approaches, such as alternative cytokine detection and using different antigens, are considered. Following this purpose, this study aims to evaluate the addition of EspC, EspF and Rv2348-B to those present in the QuantiFERON-TB Gold In-Tube (QFN-G-IT). We included 115 subjects: 74 active TB patients, 17 LTBI individuals and 24 healthy controls. Whole blood samples were collected in QFN-G-IT and in-house tubes containing different combinations of EspC, EspF and Rv2348-B, together with ESAT-6, CFP-10, and TB7.7. After overnight incubation at 37 ºC, plasma was harvested and IFN-γ quantified. IFN-γ levels in the QFN-G-IT and in-house tubes correlated very good (Spearman Rho(r).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of Host Genetics and Biological Response Modifiers on Respiratory Tract Infections

  • Lacoma, Alicia|||0000-0002-2049-3872
  • Mateo, Lourdes|||0000-0002-6394-2949
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Méndez, María Jesús
  • Rodrigo Gonzalo de Líria, Carlos|||0000-0003-1140-2585
  • Latorre, Irene|||0000-0001-8159-2455
  • Villar-Hernandez, Raquel
  • Domínguez, José|||0000-0001-7888-0309
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
Host susceptibility to respiratory tract infections (RTI) is dependent on both genetic and acquired risk factors. Repeated bacterial and viral RTI, such as pneumonia from encapsulated microorganisms, respiratory tract infections related to respiratory syncytial virus or influenza, and even the development of bronchiectasis and asthma, are often reported as the first symptom of primary immunodeficiencies. In the same way, neutropenia is a well-known risk factor for invasive aspergillosis, as well as lymphopenia for Pneumocystis, and mycobacterial infections. However, in the last decades a better knowledge of immune signaling networks and the introduction of next generation sequencing have increased the number and diversity of known inborn errors of immunity. On the other hand, the use of monoclonal antibodies targeting cytokines, such as tumor necrosis factor alpha has revealed new risk groups for infections, such as tuberculosis. The use of biological response modifiers has spread to almost all medical specialties, including inflammatory diseases and neoplasia, and are being used to target different signaling networks that may mirror some of the known immune deficiencies. From a clinical perspective, the individual contribution of genetics, and/or targeted treatments, to immune dysregulation is difficult to assess. The aim of this article is to review the known and newly described mechanisms of impaired immune signaling that predispose to RTI, including new insights into host genetics and the impact of biological response modifiers, and to summarize clinical recommendations regarding vaccines and prophylactic treatments in order to prevent infections.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Tobacco Smoking and Second-Hand Smoke Exposure Impact on Tuberculosis in Children

  • Altet, Neus
  • Latorre, Irene|||0000-0001-8159-2455
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Soriano-Arandes, Antoni|||0000-0001-9613-7228
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Milà, Celia
  • Rodríguez-Fernández, Pablo|||0000-0003-1273-0548
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Godoy, Pere|||0000-0002-2896-7286
  • Millet, Joan Pau|||0000-0003-0200-2459
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez-Ruiz, Carlos A.
  • Domínguez, José|||0000-0001-7888-0309
Little is known about whether second-hand smoke (SHS) exposure affects tuberculosis (TB). Here, we investigate the association of cigarette smoke exposure with active TB and latent TB infection (LTBI) in children, analyzing Interferon-Gamma Release Assays' (IGRAs) performance and cytokine immune responses. A total of 616 children from contact-tracing studies were included and classified regarding their smoking habits [unexposed, SHS, or smokers]. Risk factors for positive IGRAs, LTBI, and active TB were defined. GM-CSF, IFN-γ, IL-2, IL-5, IL-10, IL-13, IL-22, IL-17, TNF-α, IL-1RA and IP-10 cytokines were detected in a subgroup of patients. Being SHS exposed was associated with a positive IGRA [aOR (95% CI): 8.7 (5.9-12.8)] and was a main factor related with LTBI [aOR (95% CI): 7.57 (4.79-11.94)] and active TB [aOR (95% CI): 3.40 (1.45-7.98)]. Moreover, IGRAs' sensitivity was reduced in active TB patients exposed to tobacco. IL-22, GM-CSF, IL-5, TNF-α, IP-10, and IL-13 were less secreted in LTBI children exposed to SHS. In conclusion, SHS is associated with LTBI and active TB in children. In addition, false-negative IGRAs obtained on active TB patients exposed to SHS, together with the decrease of specific cytokines released, suggest that tobacco may alter the immune response.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment

  • Díaz-Fernández, Sergio
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Fernández, Marco A.|||0000-0002-3921-2209
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Tolosa, Guillermo
  • Sánchez Montalvá, Adrián|||0000-0002-2194-5447
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Safont Gonzalez, Guillem|||0000-0001-8174-4279
  • Romero i Andrada, Iris
  • Sabrià, Josefina
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Domínguez, José|||0000-0001-7888-0309
  • Latorre, Irene|||0000-0001-8159-2455
Current blood-based diagnostic tools for TB are insufficient to properly characterize the distinct stages of TB, from the latent infection (LTBI) to its active form (aTB); nor can they assess treatment efficacy. Several immune cell biomarkers have been proposed as potential candidates for the development of improved diagnostic tools. To compare the capacity of CD27, HLA-DR, CD38 and Ki-67 markers to characterize LTBI, active TB and patients who ended treatment and resolved TB. Blood was collected from 45 patients defined according to clinical and microbiological criteria as: LTBI, aTB with less than 1 month of treatment and aTB after completing treatment. Peripheral blood mononuclear cells were stimulated with ESAT-6/CFP-10 or PPD antigens and acquired for flow cytometry after labelling with conjugated antibodies against CD3, CD4, CD8, CD27, IFN-γ, TNF-α, CD38, HLA-DR, and Ki-67. Conventional and multiparametric analyses were done with FlowJo and OMIQ, respectively. The expression of CD27, CD38, HLA-DR and Ki-67 markers was analyzed in CD4 + T-cells producing IFN-γ and/or TNF-α cytokines after ESAT-6/CFP-10 or PPD stimulation. Within antigen-responsive CD4 + T-cells, CD27 - and CD38 + (ESAT-6/CFP-10-specific), and HLA-DR + and Ki-67 + (PPD- and ESAT-6/CFP-10-specific) populations were significantly increased in aTB compared to LTBI. Ki-67 demonstrated the best discriminative performance as evaluated by ROC analyses (AUC.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Advances in diagnostic tools for respiratory tract infections, from tuberculosis to COVID-19 - changing paradigms?

  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Gonçalves-Carvalho, Filipe|||0000-0003-0665-1667
  • Marín, Alicia|||0000-0002-9358-2120
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Domínguez, José|||0000-0001-7888-0309
  • Latorre, Irene|||0000-0001-8159-2455
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
Respiratory tract infections (RTIs) are one of the most common reasons for seeking healthcare, but are amongst the most challenging diseases in terms of clinical decision-making. Proper and timely diagnosis is critical in order to optimise management and prevent further emergence of antimicrobial resistance by misuse or overuse of antibiotics. Diagnostic tools for RTIs include those involving syndromic and aetiological diagnosis: from clinical and radiological features to laboratory methods targeting both pathogen detection and host biomarkers, as well as their combinations in terms of clinical algorithms. They also include tools for predicting severity and monitoring treatment response. Unprecedented milestones have been achieved in the context of the COVID-19 pandemic, involving the most recent applications of diagnostic technologies both at genotypic and phenotypic level, which have changed paradigms in infectious respiratory diseases in terms of why, how and where diagnostics are performed. The aim of this review is to discuss advances in diagnostic tools that impact clinical decision-making, surveillance and follow-up of RTIs and tuberculosis. If properly harnessed, recent advances in diagnostic technologies, including omics and digital transformation, emerge as an unprecedented opportunity to tackle ongoing and future epidemics while handling antimicrobial resistance from a One Health perspective. Unprecedented advances have been achieved by improving and applying the latest technologies to key aspects such as epidemiology, contact tracing and diagnostics of respiratory tract infections that need to be properly addressed for global improvements.